Ocugen to Present on Modifier Gene Therapy Platform at
MALVERN, Pa., April 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering,...
Source: globenewswire.com
March Building News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from March Building. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In March Building Today - Breaking & Trending Today
Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting
MALVERN, Pa., April 26, 2024 -- Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that the...
Source: marketscreener.com
UPDATE -- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting
MALVERN, Pa., April 26, 2024 -- Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that the...
Source: marketscreener.com
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC Platform Targeting Ocular Diseases at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2024
DAEJEON, South Korea, April 23, 2024 /PRNewswire/ -- PharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public company
Source: thailand-business-news.com
The First Big Fan Con Of 2024 Kicks Off This Weekend In Seattle
More than 85,000 fans are expected at one of North America's biggest comic conventions in a hopeful sign for the industry.
Source: forbes.com